fisherboy
- 10 Mar 2008 08:49
Does anyone have an opinion on PRM.
No comparable news for a while.
Price seems to be sliding once again.
hangon
- 10 Apr 2008 11:09
- 10 of 37
It will be interesting to see what value is placed on this deal - - - it had better be good, eh?
I hold from some while ago and frankly, any excitement has long since gone.
fisherboy
- 10 Apr 2008 16:51
- 11 of 37
Well,the big announcement has came and went.
Lots of sells,but also a lot of buys.
Hopefully will end the week above the 50p mark.
halifax
- 10 Apr 2008 19:02
- 12 of 37
What is the licence worth in revenue terms?
blueface
- 11 Apr 2008 10:14
- 13 of 37
Landsbanki have said in their brief up to date note that the Thermo Fisher deal would "conservatively" add another 24p to their original target price of 62p earlier this year.
They add that the royalties to PRM would be equivalent of 20% of sales on which PRM would be making a gross margin of 80%- which net TMT-based income could be "double their conservative estimates",etc.
They also mention that the challenge which had been lodged to its European TMT patent suggets that the Thermo believes the patent is secure.
I am reliably informed that the company will be making some further announcements in coming weeks..LOL for the everlasting patient shareholders!
blueface
- 30 May 2008 10:55
- 14 of 37
Thermo Fisher will be rolling out Proteome's TMT(R)Tags at the 56th ASMS Conference on Mass Spectrometry and Applied Topics in Denver, USA from June 1st to 5th next week ...this will prove to be very interesting to see what the feedback will be !!..hopefully very positive in which case PRM shares are a steal still at current level of 39/40p!!...BUY..LOL will be on the way soon!
fisherboy
- 04 Jun 2008 16:49
- 15 of 37
Another red day.No news seems to be the norm these days.Am still patiently waiting.Has anybody any information on the Alzheimers licence,it seems to have been put on the wayside for the moment.
hangon
- 24 Jun 2008 10:38
- 16 of 37
21% down to c. 26p= = = = wow, what a waster!
Despite there being "good news soon" - something that's been "in the post..." for the last six years to my memory we investors have seen nothing. The Management of this co couldnt sell vinegar at a fish and chip convention.
. . . . . . . . . . . . . . The facts speak for themselves. . . . . . . . . . . . .
Er, Whatever they have, no-one wants .....at the price PRM wants to do a deal - that is if anyone needs a deal; for Life has gone on (on this planet) for millions of years without PRM's markers....and I guess it will continue that way...
expect 20p soon, as they will be wanting more cash to keep this beast rolling.
EDIT 01Aug08
Company expectations appear to have improved (heard that before!) with an Ann expected soon. However, as is common in small AIM-stocks no-one knows (what/ when /How-much, etc.) - so maybe we won't see 20p - more like 40p as this bears market-hallmarks of having reached its bottom.
Snodders Junior
- 09 Jul 2008 08:33
- 17 of 37
I predict a BIG ANNOUNCEMENT soon
Silent Service
- 02 Aug 2008 07:52
- 18 of 37
Market Reaction in last two days seems to indicate something coming VERY SOON.
Toya
- 02 Aug 2008 21:01
- 19 of 37
Something's going on for sure - two lots of Price Monitoring Extensions on Thurs and Fri of this week, and sp shot up. Just can't think what's going on as I've not followed this for a while, though did notice the rise in last couple of days. Think I may leap back on board first thing Monday.
Toya
- 04 Aug 2008 07:51
- 20 of 37
... on second thoughts: sp is indicating down this morning. Will keep an eye on it
hangon
- 26 Aug 2008 09:27
- 21 of 37
No obvious NEWs yet - so what caused the big rise ( almost doubled!).?
Maybe a perception that this technology has some merit and will be big one day. Maybe it's a better understanding of the Dir-Loan (being in Shareholder interest?) and so on.
Without solid news this could slip back as folk depart, taking a small profit as is tempting.....or do you hang-on in there to reaqp the potential rewards?
This Co has always told the Market there is a Big-Deal round the corner...and maybe one day there will be.
What's odd, is that with a technology so good - why aren't Drug-Co's snapping them up? . . . . . . that remains a worry, but IF there is a good deal - then this should multiply - I have a small holding from c. sub30p and somewhat more higher...I guess I might be near-evens currently, but if it goes well, I shall be happy enough.
Current Markets strip-out losers....just hope this survives OK.
I'm not feeding this one....waiting will do.
bluemango
- 26 Aug 2008 10:02
- 22 of 37
"What's odd, is that with a technology so good - why aren't Drug-Co's snapping them up?"
The director loan and its current terms involving the IP and potential conversion are in effect a 'poison pill' for any would-be predator. CJP's game-plan will probably involve an agreed takeover at some future time, but not before full value has been added. The two main cash inflows still to come are, firstly, sub-licences from current infringers of the TMT patents thus allowing TF and PRM to tap into current/future royalty streams, plus a large element for back-royalties due to PRM. Secondly they are still pursuing a 30m euros warranties claim with Sanofi-Aventis. Both could result in multi-million windfall payments to Proteome, and may be a motivation behind some of the recent buying.
This is all quite apart from possible commercial deals for HTS biomarkers and for Alzheimer's biomarkers.
Nothing new in the above of course, which is why the Company still have something of a credibility hill to climb. So until any of the above actually occur, there's still an element of gamble here, but with corporate activity involving ABI this Autumn, the odds are at last looking to shift in Proteome's favour.
hangon
- 01 Sep 2008 10:37
- 23 of 37
Bluemango, yes I agree about that loan - yet the story from the company was started nearly ten years ago - so why didn't any Big Pharma want it then?....mainly punters bought shares . . . and that was the start of their/our woes.
Seems to me that many large-Co's don't look to their furture. By watching nascent technologies they might be able to ride the wave well into the future. No, I'm not suggesting a buy-out, just a "initerest" with maybe some assistance by way of Management expertise...
So, let's hope it is starting to come true, eh?
bluemango
- 03 Sep 2008 12:34
- 24 of 37
Big pharma tend to be ultra-cautious and move at absolute snail pace. They certainly wouldn't have risked resources on unproven technology ten years ago, particularly bearing in mind this would have been before PRM acquired the rights to the TMT technology via Xzillion.
Now, they are also still unlikely to make a move while, in theory, the patent situation is on the face of it unclear with an ABI objection to PRM's patent still outstanding. However the key to movement here will be EPO clarification of the patent situation (unless Invitrogen/ABI decide to settle beforehand) and with Thermo Fisher then obtaining a license from ABI - with back-royalties due to PRM dating back to 2004.
hangon
- 03 Oct 2008 11:39
- 25 of 37
This Patent-issue is a worry, that after so long we discover there is a broken patio-door round the back of the castle. Tad careless, or is this "claim" opportunistic I wonder. This is unlikely since no professionals would associate themselves with a trivial claim, so I suspect it has some merit, however small. This will drag on the shares, although this morming they are up on "no-news".
We'll just have to wait a lot longer, I fear.
Obe2konobi
- 07 Oct 2008 18:49
- 26 of 37
Such Pessimism from the pair of you. I say the pair of you because this has to be one of the least used boards on the Proteome saga. I have only held shares for a relitely short period of their history but have held long enough to see them swing from 45p down to 18 or so then right back up to 42 recently. All the while wishing I had a crystal ball to take advantage of what for some was a 100% gain within around two weeks.
I hear what your saying Hangon regarding the patent issue but lets not forget that Thermo Fisher came on board already knowing that ABI were challenging again. I think I am correct in saying again as I believe Proteome has already won in court regarding the Patents once. This challenge is little different from the first lost case for ABI and this I believe is why Thermo Fisher are happy to be on board before the result of what they can only judge to be another win for Proteome. These people have the best legal advice possible and they would have done there own extensive research into the possibilities of loosing this challenge. It seems like mere/sour grapes stalling tactics on ABI's behalf.
As Bluemango suggested, it may get settled beforehand to avoid more costs than already mounting. At the time ABI didn't know that Thermo Fisher was going to go on board with proteome and may have thought that a long drawn out challenge could have seen the back of Proteome or a buy out. Just my thoughts.
I think the next six months will bare fruit...how much in this insanely turbulent market is anybodies guess. Good news these days can see a healthy days gain only to be forgotten and lost a few days after for no other reason than blind panic selling or "market conditions" ! A lovely saying for those companies with little to do with any of the recent problems seeing their value slide away as if they were the cause of it.....I'm not bitter !!! :o) Obe2
hangon
- 24 Oct 2008 16:24
- 27 of 37
Obe2konobi , Yes I think much of what you say about the Legal issue could be true - "opportunism" -
However, this dismisses the key issue that they are always supposed to be "near" a deal yet even with Fisher there seems to be Great Silence.
My understanding is that "proetomics" give a clear indication to the correct drug-treatment; explaining variations in patients taking the same stuff, etc. so why isn't this Red-Hot? [EDIT:-However, I'm wondering if it has the ability to create more information than is good for us - for example a pH-test gives a colour and you compare this agqainst a chart. If however you put the test-strip into a machine which prints out the whole works of shakespere (as it were), you have more work to do and a lot more time is wasted, etc.].
Think of the money the NHS spends; which by correct "targeting" the effects could double, say ....and it should be evident the NHS requires half the drugs, since they don't give patients the "wrong stuff".
However, I'm not sure that PRM is "yet" at this simplistic stage, rather like in the early days of photography, B&W is nice but colour would be better, then along come PRM with a process that gives you colour - except they only have yellow.......very exciting I don't think....and until PRM manages to convey what it's got ( to shareholders) they will be stuck in this yo-yo region, drifting now because of the general-woes.
And still there is silence . . . just how long do shareholders have to wait for some return? . . . . . Grr.
EDIT -(18Jn09)-Oh deary, result out and sp falls . . . . you have to wonder at the patience of shareholders in this kingdom.
hlyeo98
- 24 Jan 2010 19:29
- 28 of 37
hangon
- 25 May 2010 15:04
- 29 of 37
I think they need to empty the fridges in the executive suite wherever they sleep.
(that's where the smell is)
Good to read that Share-Options are still considered part of Exec. pay . . . . . . .........Grr.
(This stock has lost 2/3 value since 2007 - DYOR -) - 24p mid today on small trades, nearly even despite a 10% push by MM's.
EDIT (20Nov2010)- SP has risen, presumably a few months of no bad News - we needed it!, now 36p-ish DYOR.
EDIT (11Feb2011) -slipped to 34p after a rise, due to Jan Contract win.
EDIT (5Sept2013)-; Yawn,- Peaked 70p 2013 now dn at 46p . . . oh deary, how dreary . . .
((EDIT))Dec2016...Looking back 10years - easily 90% Club - it's now 5.5p